LEADER 01124nam0-2200361---450- 001 990009929310403321 005 20150417113207.0 010 $a3-9801863-3-4 035 $a000992931 035 $aFED01000992931 035 $a(Aleph)000992931FED01 035 $a000992931 100 $a20150114d1995----km-y0itay50------ba 101 0 $ager 102 $aDE 105 $aa-------001yy 200 1 $aSalus vom Staatskult zur politischen Idee$eeine archäologische Untersuchung$fLorenz Winkler 210 $aHeidelberg$cVerlag Archaologie und Geschichte$d1995 215 $a226 p., 11 p. di tav.$cill.$d30 cm 225 1 $aArchäologie und Geschichte$v4 610 0 $aImmagini sacre$aRoma antica 610 0 $aRoma$aVita religiosa 610 0 $aSalus 610 0 $aSimbolismo nell'arte$aRoma 676 $a704.9489207 700 1$aWinkler,$bLorenz$0330151 801 0$aIT$bUNINA$gRICA$2UNIMARC 901 $aBK 912 $a990009929310403321 952 $a704.948 WIN 1$bBRAU 2015/27$fFLFBC 959 $aFLFBC 996 $aSalus vom Staatskult zur politischen Idee$9821783 997 $aUNINA LEADER 08167nam 22007815 450 001 9910364951803321 005 20250610110357.0 010 $a3-7091-1544-2 024 7 $a10.1007/978-3-7091-1544-2 035 $a(CKB)4100000010011960 035 $a(MiAaPQ)EBC5996457 035 $a(DE-He213)978-3-7091-1544-2 035 $a(PPN)24281753X 035 $a(MiAaPQ)EBC29090868 035 $a(EXLCZ)994100000010011960 100 $a20191212d2019 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aImaging Brain Diseases $eA Neuroradiology, Nuclear Medicine, Neurosurgery, Neuropathology and Molecular Biology-based Approach /$fby Serge Weis, Michael Sonnberger, Andreas Dunzinger, Eva Voglmayr, Martin Aichholzer, Raimund Kleiser, Peter Strasser 205 $a1st ed. 2019. 210 1$aVienna :$cSpringer Vienna :$cImprint: Springer,$d2019. 215 $a1 online resource (2,282 pages) 311 08$a3-7091-1543-4 327 $aPart I. The techniques -- 1. Imaging modalities - Radiology -- 1.1. CT -- 1.2. MR Imaging -- 1.3. MR Spectroscopy -- 1.4. Perfusion imaging -- 1.5. Diffusion-weighted imaging (DWI) -- 1.6. Diffusion Tensor Imaging (DTI) -- 1.7. Functional MRI (fMRI) -- 2. Imaging modalities - Nuclear Medicine -- 2.1. SPECT -- 2.2. PET - [11 C]-Methionine (MET) -- 2.3. PET - [18 F]-Fluordeoxyglucose (FDG) -- 2.4. PET - [18 F]-Fluorethyltyrosine (FET) -- 2.5. PET - [18 F]-Fluorothymidine (FLT) -- 2.6. PET - [18 F]-Fluorodihydroxyphenylalanine (DOPA) -- 3. Imaging Modalities - Neuropathology -- 3.1. Gross-anatomy -- 3.2. Histology -- 3.3. Immunohistochemistry -- Part II. The normal human brain -- 4. The normal human brain -- 4.1. Subdivisions of the nervous system -- 4.2. Gross-anatomy of the nervous system -- 4.3. Ventricular system ? Cerebrospinal fluid ? Barriers -- 4.4. Meninges -- 4.5. Histological constituents of the nervous system -- 4.6. Microscopical built-up of the nervous system -- 4.7. Functional systems -- 5. Vascular supply of the brain -- 5.1. Arterial supply -- 5.2. Venous drainage -- Part III. The brain diseases ? Edema and Hydrocephalus -- 6. Brain edema -- 7. Hydrocephalus -- Part IV -- The Brain diseases ? Vascular system -- 8. Vascular disorders ? Hypoxia -- 9. Vascular disorders ? Ischemic lesions -- 10. Vascular disorders ? Hemorrhage -- 11. Vascular disorders ? Angiopathies -- Part V. The brain diseases ? Infections -- 12. Infections ? Bacteria -- 13. Infections ? Viruses -- 14. Infections ? Parasites -- 15. Infections ? Fungi -- 16. Prion diseases -- Part VI. The brain diseases ? Aging and neurodegeneration -- 17. Normal aging brain -- 18. Neurodegenerative disorders - Alzheimer's disease -- 19. Neurodegenerative disorders ? Lewy body disease -- 20. Neurodegenerative disorders ? Fronto-temporal lobe dementia -- 21. Neurodegenerative disorders ? Multi-infarct dementia -- 22. Neurodegenerative disorders ? Binswanger disease -- 23. Neurodegenerative disorders ? Progressive supranuclear palsy -- 24. Neurodegenerative disorders - Parkinson's disease -- 25. Neurodegenerative disorders ? Amyotrophic lateral sclerosis -- 26. Neurodegenerative disorders ? Huntington disease -- Part VII. The brain diseases ? Myelin disorders -- 27. Demyelinating diseases ? Multiple Sclerosis -- 28. Neuromyelitis optica -- 29. ADEM -- Part VIII. The brain diseases ? Epilepsy -- 30. Temporal lobe epilepsy -- 31. Cortical dysplasia -- Part IX. The brain diseases ? Tumors -- 35. Tumors of the nervous system ? General considerations -- 36. Tumors ? Astrocytoma WHO II ? Anaplastic Astrocytoma WHO III -- 37. Tumors ? Glioblastoma WHO IV -- 38. Tumors ? Gliosarcoma WHO IV ? Giant cell Glioblastoma WHO IV -- 39. Tumors ? Pilocytic astrocytoma WHO I -- 40. Tumors ? Oligodendroglioma WHO II ? Anaplastic oligodendroglioma WHO III -- 41. Tumors ? Oligo-astrocytoma WHO II ? Anaplastic Oligo-Astrocytoma WHO III -- 42. Ependymal tumors -- 43. Choroid plexus tumors ? Papilloma ? Carcinoma -- 44. Neuronal and mixed neuronal-glial tumors -- 45. Pineal parenchymal tumors -- 46. Embryonal tumors -- 47. Tumors of cranial and spinal nerves ? Schwannoma -- 48. Tumors of cranial and spinal nerves ? Neurofibroma -- 49. Tumors of cranial and spinal nerves ? Perineuroma -- 50. Tumors of cranial and spinal nerves ? Malignant peripheral nerve sheath tumor (MPNST) -- 51. Tumors of meningothelial cells -- 52. Mesenchymal, non-meningothelial tumors -- 53. Lymphomas and haematopoetic neoplasms -- 54. Germ cell tumors -- 55. Cysts and tumor-like lesions -- 56. Tumors of the sellar region -- 57. Metastatic tumors -- 58. Paraneoplastic syndromes ? Autoimmune diseases -- 59. Radiation injury. 330 $aThis book illustrates in a unique way the most common diseases affecting the human nervous system using different imaging modalities derived from radiology, nuclear medicine, and neuropathology. The features of the diseases are visualized on computerized tomography (CT)-scans, magnetic resonance imaging (MRI)-scans, nuclear medicine scans, surgical intraoperative as well as gross-anatomy and histology preparations. For each disease entity, the structural changes are illustrated in a correlative comparative way based on the various imaging techniques. The brain diseases are presented in a systematic way allowing the reader to easily find the topics in which she or he is particularly interested. In Part 1 of the book, the imaging techniques are described in a practical, straightforward way. The morphological built-up of the normal human brain and its vascular supply are presented in Part 2. The chapters of the subsequent Parts 3 to 10 deal with the following diseases involving the nervous system including: hemodynamic, vascular, infectious, neurodegenerative, demyelination, epilepsy, trauma and intoxication, and tumors. The authors incite the clinician to see the cell, the tissue, the organ, the disorder by enabling him to recognize brain lesions or interpreting histologic findings and to correlate this knowledge with molecular biologic concepts. Thus, this book bridges the gap between neuro-clinicians, neuro-imagers and neuro-pathologists. The information provided will facilitate the understanding of the disease processes in the daily routine work of neurologists, neuroradiologists, neurosurgeons, neuropathologists, and all allied clinical disciplines. 606 $aNervous system$xRadiography 606 $aNeurology 606 $aNuclear medicine 606 $aPathology 606 $aNervous system$xSurgery 606 $aNeuroradiology 606 $aNeurology 606 $aNuclear Medicine 606 $aPathology 606 $aNeurosurgery 606 $aMalalties cerebrals$2thub 606 $aDiagnòstic per la imatge$2thub 608 $aLlibres electrònics$2thub 615 0$aNervous system$xRadiography. 615 0$aNeurology. 615 0$aNuclear medicine. 615 0$aPathology. 615 0$aNervous system$xSurgery. 615 14$aNeuroradiology. 615 24$aNeurology. 615 24$aNuclear Medicine. 615 24$aPathology. 615 24$aNeurosurgery. 615 7$aMalalties cerebrals. 615 7$aDiagnòstic per la imatge 676 $a616.804757 700 $aWeis$b Serge$4aut$4http://id.loc.gov/vocabulary/relators/aut$01060602 702 $aSonnberger$b Michael$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aDunzinger$b Andreas$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aVoglmayr$b Eva$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aAichholzer$b Martin$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aKleiser$b Raimund$4aut$4http://id.loc.gov/vocabulary/relators/aut 702 $aStrasser$b Peter$4aut$4http://id.loc.gov/vocabulary/relators/aut 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910364951803321 996 $aImaging Brain Diseases$92514557 997 $aUNINA LEADER 04741nam 22006375 450 001 9910743685803321 005 20251008140721.0 010 $a3-031-36386-8 024 7 $a10.1007/978-3-031-36386-3 035 $a(MiAaPQ)EBC30727039 035 $a(Au-PeEL)EBL30727039 035 $a(DE-He213)978-3-031-36386-3 035 $a(CKB)28141359300041 035 $a(EXLCZ)9928141359300041 100 $a20230901d2023 u| 0 101 0 $aeng 135 $aurcnu|||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aIntellectual Property Statistics $eMeasuring Framework for Standards and Trade in Ideas /$fby Eskil Ullberg 205 $a1st ed. 2023. 210 1$aCham :$cSpringer International Publishing :$cImprint: Springer,$d2023. 215 $a1 online resource (194 pages) 225 1 $aContributions to Economics,$x2197-7178 311 08$aPrint version: Ullberg, Eskil Intellectual Property Statistics Cham : Springer International Publishing AG,c2023 9783031363856 327 $a1. Introduction -- 2. Theory of Value -- 3. Today?s Balance of Payment Statistics and Data Gap -- 4. Today?s Financial Accounting Standards and Data Gap -- 5. Overview of the Framework -- 6. Description of the Collection and Compilation of Data for each Element -- 7. A Proof-of-Concept Study in Perú -- 8. Can Data be Collected in a Developing Nation?- 9. Future Steps Towards New Standards and Statistics. 330 $aPatents and other intellectual property (IP) rights are increasingly part of cross-border trade in their own rights. Patent transfers and patent licensing between inventors, investors and innovators create new business strategies of cooperation in the creation of new technology ? increasing the productivity in the stock of technology assets ? and efficient ?distribution? of these rights. The rights bundles are then used ? also increasingly ? in products and services being traded cross-border, furthering economic efficiency created by this cooperative strategy. Today?s international trade statistics, however, lack statistics explicitly on trade flows from ideas, based on IP rights. This book offers an idea based statistical framework to measure IP, (i.e., increasingly depends on trade in ideas) and explores ways to introduce the framework into international standards. Specifically, it offers a theory of value to measure the flows from IP and an asset view of IP to deal with allocation of resources and who owns these rights. This is then contrasted with the current way IP is treated and a ?gap analysis? is used to identify what needs to change in the standards. This new framework can help develop theories, policies, practices and inform the decisions needed to better leverage the human capital formation of inventors everywhere. Praise for Intellectual Property Statistics? ?In this book, Prof. Ullberg has undertaken a Herculean task ? to lay out a paradigm for the collection of IP Statistics to ensure that the ? market of trade in ideas has the information and data necessary to function well. [the] volume should be viewed as a starting point, a work in progress, but an important one that could very well influence the development of this important set of data on trade in ideas. At a time when global issues ? require both new ideas and the spread of those ideas widely to help ensure botheconomic growth and continued global economic convergence data that helps us monitor and evaluate what is happening in trade in ideas will be extremely valuable.? ? Robert Koopman, American University, Washington, DC, USA and Former Chief Economist, World Trade Organization, Geneva, Switzerland. 410 0$aContributions to Economics,$x2197-7178 606 $aInternational trade 606 $aStatistics 606 $aTechnological innovations 606 $aSampling (Statistics) 606 $aInternational Trade 606 $aApplied Statistics 606 $aEconomics of Innovation 606 $aMethodology of Data Collection and Processing 615 0$aInternational trade. 615 0$aStatistics. 615 0$aTechnological innovations. 615 0$aSampling (Statistics) 615 14$aInternational Trade. 615 24$aApplied Statistics. 615 24$aEconomics of Innovation. 615 24$aMethodology of Data Collection and Processing. 676 $a346.048 676 $a346.048 700 $aUllberg$b Eskil$01228298 701 $aKoopman$b Robert$01427241 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910743685803321 996 $aIntellectual Property Statistics$93560154 997 $aUNINA